...
首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >Advanced neonatal medicine in China: a quantitative analysis of research productivity and impact factors
【24h】

Advanced neonatal medicine in China: a quantitative analysis of research productivity and impact factors

机译:中国先进新生药:研究生产力和影响因素的定量分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To summarize academic productivity of neonatal medicine in China and explore its relationship with health care workforce and activities. Methods: We retrospectively extracted data from national key clinical subspecialty proposals, and used accessible databases as Science Citation Index (SCI), PubMed, and National Natural Science Foundation of China. Results: Between 2008 and 2010, 61 newborn units at the most advanced level in 31 cities from 28 of 31 provincial districts in mainland China were included. Fifty-two national or international projects and 111 provincial projects were conducted. A total of 171 articles were listed in the SCI database; 23 patents were registered. There were 83 oral presentations in international conferences abroad. One national and 40 provincial government awards were received. Health workforce indexes, such as physicians with MD&PhD degrees, were significantly related to academic productivity. National or international projects (β = .285, p<.001; 95% Cl = 0.179, 0.391) and the number of newborn beds (β = .005, p = .016; 95% CI = 0.001, 0.008) were two underlying factors to determine government awards (adjusted R2 = .426). The 10 main cities for neonatal medicine research were also listed. Conclusion: In this study, we established the baseline information on neonatal medicine research in China, which could provide information for further practice.
机译:目标:总结中国新生药的学术生产力,探索其与医疗保健劳动力和活动的关系。方法:我们回顾性地提取了来自国家关键临床亚专业提案的数据,并使用了作为科学引文指数(SCI),PubMed和国家自然科学基金的可访问数据库。结果:2008年至2010年间,包括来自中国大陆31个省级28个省级地区的31个城市最先进的61个新生儿单位。进行了五十二个国家或国际项目和111个省级项目。 SCI数据库中列出了171篇文章;注册了23项专利。国外国际会议有83个口头介绍。收到了一个国家和40个省政府奖项。卫生员工指数,如医学博士学位和博士学位,与学术生产力有关。国家或国际项目(β= .285,P <.001; 95%CL = 0.179,0.391)和新生床的数量(β= .005,P = .016; 95%CI = 0.001,0.008)是两个确定政府奖励的潜在因素(调整后的R2 = .426)。还列出了新生药研究的10个主要城市。结论:在这项研究中,我们建立了中国新生药研究的基线信息,可以提供进一步做法的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号